The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
D-Alanine Added to Antipsychotics for the Treatment of Schizophrenia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
(1976) · Medical Entomology and Zoology · Cited by 8,899
Hollmann, M., & Heinemann, S. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.000335 · Cited by 3,975
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
A Rating Scale for Drug-Induced Akathisia
Barnes, T. R. E. (1989) · British Journal of Psychiatry · doi:10.1192/bjp.154.5.672 · Cited by 2,170
Psychopharmacology: The Third Generation of Progress.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-509_2 · Cited by 2,014
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection
Oldendorf, W. (1971) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1971.221.6.1629 · Cited by 1,683
McDonald, J. W., & Johnston, M. V. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90011-c · Cited by 1,416
Risperidone in the treatment of schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.457 · Cited by 891
The schedule for the deficit syndrome: An instrument for research in schizophrenia
Kirkpatrick, B., Buchanan, R. W., McKenny, P. D., Alphs, L. D., & Carpenter, W. T. (1989) · Psychiatry Research · doi:10.1016/0165-1781(89)90153-4 · Cited by 808
Malhotra, M. D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00036-5 · Cited by 680
Effects of Ketamine in Normal and Schizophrenic Volunteers
Lahti, A. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00243-3 · Cited by 674
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577
Self-citationD-serine added to antipsychotics for the treatment of schizophrenia
Tsai, G., Yang, P., Chung, L.-C., Lange, N., & Coyle, J. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00279-0 · Cited by 571
Self-citationThe Glutamatergic Dysfunction Hypothesis for Schizophrenia
Coyle, J. T. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017192 · Cited by 568
Efficacy of High-Dose Glycine in the Treatment of Enduring Negative Symptoms of Schizophrenia
Heresco-Levy, U., Javitt, D. C., Ermilov, M., Mordel, C., Silipo, G., & Lichtenstein, M. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.29 · Cited by 487
Quetiapine in Patients With Schizophrenia: A High- and Low-Dose Double-blind Comparison With Placebo
Small, J. G. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830180067009 · Cited by 478
Abnormal Excitatory Neurotransmitter Metabolism in Schizophrenic Brains
Tsai, G. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950220039008 · Cited by 455
Self-citationGoff, D. C., Tsai, G., Levitt, J., Amico, E., Manoach, D., Schoenfeld, D. A., Hayden, D. L., McCarley, R., & Coyle, J. T. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.1.21 · Cited by 436
Self-citationSchell, M. J., Brady Jr., R. O., Molliver, M. E., & Snyder, S. H. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01604.1997 · Cited by 415
Excitotoxic Amino Acids and Neuropsychiatric Disorders
Olney, J. W. (1990) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.000403 · Cited by 406
Regulation of NMDA receptor desensitization in mouse hippocampal neurons by glycine
Mayer, M. L., Vyklicky, L., & Clements, J. (1989) · Nature · doi:10.1038/338425a0 · Cited by 398
Endogenous d‐Serine in Rat Brain: N‐Methyl‐d‐Aspartate Receptor‐Related Distribution and Aging
Hashimoto, A., Nishikawa, T., Oka, T., & Takahashi, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03219.x · Cited by 361
Amelioration of negative symptoms in schizophrenia by glycine
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.8.1234 · Cited by 354
Tsai, G., Lane, H.-Y., Yang, P., Chong, M.-Y., & Lange, N. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.012 · Cited by 342
Self-citationMatsui, T., Sekiguchi, M., Hashimoto, A., Tomita, U., Nishikawa, T., & Wada, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010454.x · Cited by 334
Free d-aspartate and d-serine in the mammalian brain and periphery
Hashimoto, A., & Oka, T. (1997) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00019-1 · Cited by 330
The Glycine Site on the NMDA Receptor: Structure-Activity Relationships and Therapeutic Potential
Leeson, P. D., & Iversen, L. L. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00050a001 · Cited by 315
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.6.782 · Cited by 306
Hashimoto, A., Nishikawa, T., Oka, T., Takahashi, K., & Hayashi, T. (1992) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/0378-4347(92)80300-f · Cited by 305
Kristensen, J. D., Svensson, B., & Gordh, T. (1992) · Pain · doi:10.1016/0304-3959(92)90266-e · Cited by 301
A “Glutamatergic Hypothesis” of Schizophrenia: Rationale for Pharmacotherapy with Glycine
Deutsch, S. I., Mastropaolo, J., Schwartz, B. L., Rosse, R. B., & Morihisa, J. M. (1989) · Clinical Neuropharmacology · doi:10.1097/00002826-198902000-00001 · Cited by 268
Five-Factor Model of Schizophrenia Initial Validation
LINDENMAYER, J.-P., BERNSTEIN-HYMAN, R., & GROCHOWSKI, S. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199411000-00006 · Cited by 258
Heresco-Levy, U., Javitt, D. C., Ermilov, M., Mordel, C., Horowitz, A., & Kelly, D. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.5.610 · Cited by 255
Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1213 · Cited by 243
Evaluation of Treatment-Resistant Schizophrenia
Conley, R. R., & Buchanan, R. W. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.4.663 · Cited by 238
Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices
Thomson, A. M., Walker, V. E., & Flynn, D. M. (1989) · Nature · doi:10.1038/338422a0 · Cited by 233
Hashimoto, A., Oka, T., & Nishikawa, T. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00687.x · Cited by 232
High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia
Heresco-Levy, U., Ermilov, M., Lichtenberg, P., Bar, G., & Javitt, D. C. (2004) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00707-8 · Cited by 222
Hashimoto, A., Nishikawa, T., Konno, R., Niwa, A., Yasumura, Y., Oka, T., & Takahashi, K. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90476-2 · Cited by 211
Gene knockout of glycine transporter 1: Characterization of the behavioral phenotype
Tsai, G., Ralph-Williams, R. J., Martina, M., Bergeron, R., Berger-Sweeney, J., Dunham, K. S., Jiang, Z., Caine, S. B., & Coyle, J. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402662101 · Cited by 190
Self-citationFree D-aspartate and D-alanine in normal and Alzheimer brain
Fisher, G. H., D'Aniello, A., Vetere, A., Padula, L., Cusano, G. P., & Man, E. H. (1991) · Brain Research Bulletin · doi:10.1016/0361-9230(91)90266-m · Cited by 185
D-cycloserine added to clozapine for patients with schizophrenia
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1628 · Cited by 182
Heresco-Levy, U., Ermilov, M., Shimoni, J., Shapira, B., Silipo, G., & Javitt, D. C. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.480 · Cited by 167
McBain, C. J., Kleckner, N. W., Wyrick, S., & Dingledine, R. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09633-6 · Cited by 164
Clinical Efficacy of Clozapine in Treatment-Refractory Schizophrenia: An Overview
Kane, J. M. (1992) · The British Journal of Psychiatry · doi:10.1192/s0007125000296918 · Cited by 147
D-serine antagonized phencyclidine- and MK-801-induced stereotyped behavior and ataxia
Contreras, P. C. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90015-j · Cited by 121
GOFF, D. C., Herz, L. R., Posever, T. A., Shih, V. E., Tsai, G. E., Henderson, D. C., Freudenreich, O., Evins, A. E., Yovel, I., Zhang, H., et al. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2032-2 · Cited by 116
Self-citationEfficacy and tolerance of D-cycloserine in drug-free schizophrenic patients
van Berckel, B. N. M., Hijman, R., van der Linden, J. A., Westenberg, H. G. M., van Ree, J. M., & Kahn, R. S. (1996) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00311-3 · Cited by 109
Kumashiro, S., Hashimoto, A., & Nishikawa, T. (1995) · Brain Research · doi:10.1016/0006-8993(95)00307-c · Cited by 108
The Phencyclidine-Glutamate Model of Schizophrenia
Halberstadt, A. L. (1995) · Clinical Neuropharmacology · doi:10.1097/00002826-199506000-00004 · Cited by 104
Drug-induced extrapyramidal disorders.
Chase, T. N. (1972) · PubMed · Cited by 104
Tanii, Y., Nishikawa, T., Hashimoto, A. S., & Takahashi, K. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38840-3 · Cited by 101
van Berckel, B. N. M., Evenblij, C. N., van Loon, B. J., Maas, M. F., van der Geld, M. A. M., Wynne, H. J. A., van Ree, J. M., & Kahn, R. S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00014-7 · Cited by 93
Leiderman, E. A., Zylberman, I., Zukin, S. R., Cooper, T. B., & Javitt, D. C. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00585-4 · Cited by 92
Herdon, H. J., GODFREY, F., Brown, A. M., Coulton, S., Evans, J. R., & Cairns, W. J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00043-0 · Cited by 91
Excitatory Amino Acid Receptors in Schizophrenia
Ułas, J., & Cotman, C. W. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.1.105 · Cited by 89
Chairoungdua, A., Kanai, Y., Matsuo, H., Inatomi, J., Kim, D. K., & Endou, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107517200 · Cited by 81
Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia
Tsai, G. E., van Kammen, D. P., Chen, S., Kelley, M. E., Grier, A., & Coyle, J. T. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00151-6 · Cited by 80
Self-citationDual effect of glycine on NMDA-induced neurotoxicity in rat cortical cultures
McNamara, D., & Dingledine, R. J. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-12-03970.1990 · Cited by 66
Banerjee, S., Zuck, L., Yablonsky-Alter, E., & Lidsky, T. I. (1995) · Neuroreport · doi:10.1097/00001756-199512150-00014 · Cited by 63
Fletcher, E. J., & MacDonald, J. F. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90148-b · Cited by 59
Glycine Site Agonists of the NMDA Receptor: A Review
D’Souza, D. C., Charney, D. S., & Krystal, J. H. (1995) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1995.tb00285.x · Cited by 59
Iwama, H., Takahashi, K., Kure, S., Hayashi, F., Narisawa, K., Tada, K., Mizoguchi, M., Takashima, S., Tomita, U., & Nishikawa, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6184 · Cited by 57
Heresco‐Levy, U., Silipo, G. S., & Javitt, D. (1996) · PubMed · Cited by 53
Amino acid levels in d-alanine-administered mutant mice lacking d-amino acid oxidase
Nagata, Y., Konno, R., & Niwa, A. (1994) · Metabolism · doi:10.1016/0026-0495(94)90059-0 · Cited by 52
Formation of d ‐Serine from l ‐Phosphoserine in Brain Synaptosomes
Wood, P. L., Hawkinson, J. E., & Goodnough, D. B. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67041485.x · Cited by 44
Tanii, Y., Nishikawa, T., Hashimoto, A., & Takahashi, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)91546-d · Cited by 37
Umino, A., Takahashi, K., & Nishikawa, T. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701830 · Cited by 32
d-CPPene (SDZ EAA-494)—A Competitive NMDA Antagonist
Herrling, P. L., Emre, M., & Watkins, J. C. (1997) · Elsevier eBooks · doi:10.1016/b978-012546820-6/50004-9 · Cited by 25
Cited by
Glutamate receptor ion channels
Mayer, M. L. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.05.004 · Cited by 3,640
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
Astrocyte Control of Synaptic Transmission and Neurovascular Coupling
Haydon, P. G., & Carmignoto, G. (2006) · Physiological Reviews · doi:10.1152/physrev.00049.2005 · Cited by 1,323
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988
Metadata
- Authors
- Tsai, G. E., Yang, P., Chang, Y.-C., & Chong, M.-Y.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 59
- Issue
- 3
- Pages
- 230-234
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1971964419
- Cited by
- 674
- References
- 77
- FWCI
- 25.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.